Boehringer to cut costs by 15%

Boehringer Ingelheim plans to cut costs by around 15%, which means layoffs. PMLive found the pink-slip item in the German paper Frankfurter Allgemeine Zeitung. The news comes one day after the firm announced disappointing financials for the first half of the year—prescription sales slid 5.4%, to $6.4 billion. The company attributed part of the falloff to deeper discounts required to fit into the post-healthcare-reform marketplace in the US.

PMLive says it is unclear if the layoffs will be distributed throughout the global 45,000-employee workforce or limited to Germany.

You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.